awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38215269-28CBE528-4C23-4DCF-8D3B-5A29EBE1549C
Q38215269-28CBE528-4C23-4DCF-8D3B-5A29EBE1549C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38215269-28CBE528-4C23-4DCF-8D3B-5A29EBE1549C
Gemtuzumab ozogamicin in acute myeloid leukemia revisited.
P2860
Q38215269-28CBE528-4C23-4DCF-8D3B-5A29EBE1549C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38215269-28CBE528-4C23-4DCF-8D3B-5A29EBE1549C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e23b7d0a144abc3baa3d91170bf6924abe275bba
P2860
High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.